NCT06189404View on ClinicalTrials.gov

Effect of Tigulixostat on the Pharmacokinetics of Theophylline

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

November 13, 2023

Study Completion Date

November 30, 2023

Conditions
GoutHyperuricemia
Interventions
DRUG

Tigulixostat

300 mg oral dose

DRUG

Theophylline

400 mg oral dose

Trial Locations (1)

78744

PPD - Austin Research Unit, Austin

Sponsors

Lead Sponsor

LG Chem
All Listed Sponsors
lead

LG Chem

INDUSTRY

NCT06189404 - Effect of Tigulixostat on the Pharmacokinetics of Theophylline | Biotech Hunter | Biotech Hunter